| AAV | Adeno-associated virus |
| AD-MSCs | Adipose-derived mesenchymal stromal cells |
| ATMP | Advanced therapy medicinal product |
| B-ALL | B-cell acute lymphoblastic leukemia |
| bFGF | Basic fibroblast growth factor |
| BM-MSC | Bone marrow-derived mesenchymal stromal cell |
| CAF | Cancer-associated fibroblast |
| CTC | Circulating tumor cell |
| CXCL12 | C-X-C motif chemokine ligand 12 (stromal cell-derived factor-1, SDF-1) |
| CXCR4 | C-X-C chemokine receptor type 4 |
| EGF | Epidermal growth factor |
| EMT | Epithelial-to-mesenchymal transition |
| ERK | Extracellular signal-regulated kinase |
| EV | Extracellular vesicle |
| GDEPT | Gene-directed enzyme prodrug therapy |
| HCC | Hepatocellular carcinoma |
| HE | Hospital exemption |
| HGF | Hepatocyte growth factor |
| HIF-1α | Hypoxia-inducible factor-1 alpha |
| HLA-DR | Human leukocyte antigen—DR isotype |
| HSV-TK | Herpes simplex virus thymidine kinase |
| IDO | Indoleamine 2,3-dioxygenase |
| IFN-β | Interferon-beta |
| IL-6 | Interleukin-6 |
| IL-8 | Interleukin-8 |
| IL-10 | Interleukin-10 |
| ITGA5 | Integrin alpha-5 |
| LLC | Lewis lung carcinoma |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MET | Mesenchymal-to-epithelial transition |
| MNP | Magnetic nanoparticle |
| MSC | Mesenchymal stromal/stem cell |
| MSC-EV | Mesenchymal stromal/stem cell-derived extracellular vesicle |
| NK | Natural killer (cell) |
| NSCLC | Non-small cell lung cancer |
| NTR | Nitroreductase |
| OV / OVs | Oncolytic virus / oncolytic viruses |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDGF | Platelet-derived growth factor |
| PDGFR-β | Platelet-derived growth factor receptor beta |
| PGE2 | Prostaglandin E2 |
| PLGA | Poly(lactide-co-glycolide) |
| PNP | Purine nucleoside phosphorylase |
| SDF-1 | Stromal cell-derived factor-1 (CXCL12) |
| TME | Tumor microenvironment |
| T-VEC | Talimogene laherparepvec |
| TGF-β | Transforming growth factor-beta |
| TK | Thymidine kinase |
| TKA168H | HSV-TK mutant variant TKA168H |
| TMZ | Temozolomide |
| TNF-α | Tumor necrosis factor-alpha |
| TRAIL | Tumor necrosis factor-related apoptosis-inducing ligand |
| VEGF | Vascular endothelial growth factor |